Statera Biopharma (formerly known as Cytocom) is a pre-clinical and clinical biopharmaceutical company that develops product candidates for treating diseases involving immune system dysfunction. It offers immunotherapies targeting autoimmune diseases and cytopenias, including thrombocytopenia, neutropenia, and anemia, as well as emerging viruses and cancers, based on a platform designed to rebalance the body’s immune system and restore homeostasis.